GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
BIONOVO INC (BNVIQ) [hlAlert]

Bionovo, Inc. is a clinical stage drug discovery and development company focusing on women?s health and cancer. The Company designs drugs derived from botanical sources, which have mechanisms of action. The Company?s drug candidate, Menerba, represents a class of receptor sub-type selective estrogen receptor
modulator (SERM) for the treatment of vasomotor symptoms of menopause, or hot flashes. The Company has designed Menerba to selectively modulate estrogen receptor beta (ERβ). In preclinical studies, Menerba inhibited tumor growth, as well as bone resorption known to cause osteoporosis, which is developed during menopause. The Company was developing BZL101, an oral anti-cancer agent for advanced breast cancer during the year ended December 31, 2008. BZL101 is designed to take advantage of the metabolism of cancer cells. BZL101 inhibits glycolysis, a metabolic pathway on which cancer cells rely.
.
( Total: 4 Current Stock Recommendations )
BIONOVO INC   (4)
Hold 25% Buy 75%
Related companies
DARA BIOSCIENCES   (2)
Buy 100%
CELSION CORP   (6)
Buy 100%
China Biologic ...   (4)
Buy 100%
ATHERSYS INC   (7)
Buy 100%
ACURA PHARMACEUTICAL   (2)
Buy 100%
China Pharma   (2)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Tenax Therapeutics ...   (2)
Buy 100%
ARCA BIOPHARMA INC.   (1)
Buy 100%
Filter by Gains:   
  
Rating:
Buy BNVIQ
down 99.96 %
BIONOVO INC (BNVI) rated Buy by Dawson James
Tuesday,  Nov 3, 2009  9:25 AM ET

Rating:
Buy BNVIQ
Bionovo (BNVI) rated BUY
Thursday,  Jun 5, 2008  8:25 AM ET

Rating:
Buy BNVIQ
down 99.98 %

Rating:
Hold BNVIQ
BIONOVO INC (BNVI) rated Market Perform by BMO Capital Markets
Tuesday,  Feb 12, 2008  9:25 AM ET

Rating:
Buy BNVIQ
down 99.99 %
BIONOVO INC (BNVI) rated Buy
Monday,  Nov 12, 2007  9:25 AM ET

Your Recent Stocks
SymbolLastChange
BNVIQ 0.00   0.00 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy